Exkivity is an oral tyrosine kinase inhibitor (TKI). The Exkivity version produced by Lucius has a specification of 40mg * 120 pills and is currently priced at $621.
The price of Exkivity may be influenced by various factors, including production costs and market demand.
What is Exkivity?Molablotinib is a novel EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitor) drug that plays an important role in the treatment of lung cancer.It ···【more】
Article source:Lucius LaosRelease date:2024-11-29Recommended:141
The price of Exkivity varies depending on a number of factors, including the version of the drug (innovator or generic), manufacturer, sales channel, and regional policies.Is Exkiv···【more】
Article source:Lucius LaosRelease date:2024-08-06Recommended:112
Exkivity is an orally targeted drug targeting EGFR gene mutations for the treatment of patients with non-small cell lung cancer who have not been treated with EGFR-targeted drugs a···【more】
Article source:Lucius LaosRelease date:2024-08-06Recommended:135
Exkivity is a targeted therapy for specific types of non-small cell lung cancer (NSCLC). Prices vary by region, sales channel, and version (innovator or generic).How much is a box ···【more】
Article source:Lucius LaosRelease date:2024-08-06Recommended:121
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: